TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00304083 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02049736 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03356821 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03557983 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT03557983 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01639261 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01577030 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03157011 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study NCT03841188 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02039362 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03902145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02431312 — Safety Biomarker (SAF): Interleukin 12
Study NCT01705080 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01257009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04882020 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04882020 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04882020 — Safety Biomarker (SAF): Interleukin 1
Study NCT04882020 — Safety Biomarker (SAF): BDNF
Study NCT02438462 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04148001 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT02848690 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02360774 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02929342 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00001869 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT01240811 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01240811 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03477461 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00404430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00827788 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02432339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02881658 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02881658 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02453087 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00117169 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03719430 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00176865 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT03226080 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01214993 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study NCT01214993 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00570258 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04325828 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00275522 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00459511 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT02271282 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04019678 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT01991197 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00311688 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00391456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00739193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02879877 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT02075437 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00004074 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00004074 — Safety Biomarker (SAF): Interleukin 12
Study NCT03082729 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03082729 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03082729 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03979911 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02355431 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02355431 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02410161 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01100840 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01100840 — Predictive Biomarker (PRD): FGFR4 mRNA
Genes: FGFR4; JTK2; TKF
Study NCT01100840 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01100840 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT01100840 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01100840 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01100840 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01100840 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01100840 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01100840 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03217578 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT01772537 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04388917 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00437606 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study NCT02577835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06121193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02315612 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03485534 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00684398 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01822834 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT03164889 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01472393 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00294996 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02178774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01264263 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01114620 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04281082 — Predictive Biomarker (PRD): ABCB4 mRNA
Genes: ABCB4; MDR3; PGY3
Study NCT02021526 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT03789643 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03789643 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00530192 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT04435730 — Predictive Biomarker (PRD): LGALS3BP mRNA
Genes: LGALS3BP; M2BP
Study NCT01651000 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04478214 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00000399 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03346369 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT00078013 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT02005848 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03879499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03879499 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04238936 — Safety Biomarker (SAF): Interleukin 1
Study NCT06770894 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06770894 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02979821 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05033249 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03003234 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03003234 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT03003234 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT04726735 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04726735 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03257592 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT00931203 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00413608 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01316146 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02307227 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03064711 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02761057 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01895725 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01895725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT04315376 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study NCT04315376 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT02683525 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03732391 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03757169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04641897 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00414765 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00085150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT03450018 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02171637 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02171637 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02171637 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01475903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02732808 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT04634188 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02143219 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT05757271 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02279433 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT01185548 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00285090 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01023308 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT02417753 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02600286 — Pharmacodynamic Biomarker (PDY): Peripheral myelin protein 22
Genes: PMP22; GAS3
Study NCT04361422 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04361422 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04361422 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04504110 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04523571 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02616783 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04630223 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04630223 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01706367 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01552226 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04123379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT02529930 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03736382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02512393 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT03923153 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT03470220 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02702258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00449111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00333788 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04367142 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03528551 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT00246584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03113760 — Predictive Biomarker (PRD): NLRC4 mRNA
Genes: NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215
Study NCT03113760 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT03113760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03113760 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT04421378 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00426374 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03045120 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03045120 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02212262 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01936766 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01000194 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06163456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04714307 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT05520814 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03772561 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03772561 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04487847 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00384852 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT03047603 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT01443429 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04772157 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT04467840 — Predictive Biomarker (PRD): SPHK2 mRNA
Genes: SPHK2; SK2
Study NCT01133093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01133093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02134080 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study NCT00425672 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01836341 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03819569 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study NCT02687386 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02687386 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00684983 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02438722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02438722 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03880240 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00651976 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03087851 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04581824 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04581824 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04581824 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT04581824 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04581824 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05713994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04608045 — Predictive Biomarker (PRD): CPOX mRNA
Genes: CPOX; CPO; CPX
Study NCT02848300 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT01720264 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03355365 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00443755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00443755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02499003 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01734382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02201446 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT05611216 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05611216 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03629418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04141579 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04141579 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03205150 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02552849 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01159132 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT01285661 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02813928 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00876122 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT03103191 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT00734890 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00734890 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01116947 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03546569 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03546569 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02461771 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01390844 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT00479674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00479674 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01451060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02726178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00194753 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03913728 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study NCT02447679 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03375814 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT04939077 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01573000 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02745925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04363060 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03983538 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01843452 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03917719 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03871036 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02683616 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02179528 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01935089 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02104661 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT01071122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02248324 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04504526 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00343278 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT03109977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00748228 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH